Cargando…
Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy
Aberrant and exclusive expression of chromatin regulators in retinoblastoma (RB) in contrast to terminally differentiated normal retina presents a unique opportunity of selective targeting for RB. However, precise roles of these chromatin regulators in RB development and their potential as therapeut...
Autores principales: | Mao, Yu, Sun, Yu, Wu, Zhixuan, Zheng, Jingzhi, Zhang, Jianing, Zeng, Jiaqi, Lee, Chunsik, Kim, Jong Kyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660841/ https://www.ncbi.nlm.nih.gov/pubmed/34887387 http://dx.doi.org/10.1038/s41419-021-04431-y |
Ejemplares similares
-
UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress‐mediated apoptosis
por: Kim, Jong Kyong, et al.
Publicado: (2019) -
Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities
por: Lee, Chunsik, et al.
Publicado: (2022) -
Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications
por: Lee, Chunsik, et al.
Publicado: (2020) -
UHRF1 depletion sensitizes retinoblastoma cells to chemotherapeutic drugs via downregulation of XRCC4
por: He, Heng, et al.
Publicado: (2018) -
Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma
por: He, Chao, et al.
Publicado: (2019)